FDA Adverse Event Injury Summary report: N

ACUVUE 2

MDR report key: 1624983 · Received March 5, 2010

Report

Report Number
1033553-2010-00013
Event Type
Injury
Date Received
March 5, 2010
Report Date
March 5, 2010
Manufacturer
VISTAKON
Product Code
LPL
PMA / PMN Number
N18033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DEVICE LABELING SINGLE USE OR REUSE. DEVICE NOT RETURNED. NO EVALUATION WILL BE PERFORMED.

Description of Event or Problem · 1

ON 09 FEBRUARY 2010, THE J&J VISTAKON, (B) (64) AFFILIATE, REPORTED A LITERATURE SEARCH FOUND A RETROSPECTIVE STUDY PUBLISHED BY DR. YASUHISA ISHIBASHI TITLED "RECENT INCREASE OF ACANTHAMOEBA KERATITIS IN (B) (6)," WHICH WAS PUBLISHED IN (B) (6) 2010, VOLUME 3, NO.1, PP.22-29 TABLE 1, PG. 24. THIRTY REPORTED CASES OF ACANTHAMOEBA, DOCUMENTED IN JAPANESE LITERATURE, WERE EXAMINED FROM 1988 TO 2008. THE STUDY COMPARED 37 CASES EXPERIENCED FROM 1988 TO 2001 AND 30 CASES FROM 2002 AND 2008, SIX OF THE THIRTY CASES STUDIED BETWEEN 2002 AND 2008, WORE "ACUVUE" LENSES; ONE OF THE SIX CASES REPORTED WAS A BILATERAL EVENT. DR. (B) (6) WAS CONTACTED; HE INDICATED THAT THE PATIENTS WEARING "ACUVUE" PRODUCT WERE WEARING ACUVUE 2 BRAND CONTACT LENSES. THE PRODUCT AND LOT NUMBER WERE NOT AVAILABLE FOR EVALUATION AND INVESTIGATION. BASED ON THE LIMITED INFORMATION AVAILABLE, NO FURTHER INVESTIGATION CAN BE CONDUCTED AT THIS TIME. THIS MEDWATCH FORM IS TO DOCUMENT ONE OF THE SIX CASES: CASE (B) (6); PT: (B) (6)., AFFECTED EYE: OS; "DISEASE STAGE AT FIRST VISIT: INITIAL STAGE" VA AT FIRST VISIT: 0.1 (20/200); VA OUTCOME: 1.0 (20/20). WEAR SCHEDULE: DAILY WEAR, 2 WEEK REPLACEMENT. THE PATIENT RECEIVED INPATIENT TREATMENT. IF ADDITIONAL INFORMATION IS RECEIVED, WILL REPORT WITHIN 30 DAYS OF RECEIPT. ALL MDR REPORTS ARE REVIEWED AT QUARTERLY MANAGEMENT REVIEW MEETINGS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACUVUE 2 SOFT CONTACT LENS LPL VISTAKON NA

Patients

Seq Age Sex Outcome Treatment
1 19 YR Hospitalization| R